Design of Adaptive Phase 1 Clinical Trials for Dose Escalation using the DEDUCE Application

แชร์
ฝัง

ความคิดเห็น • 2

  • @aeky168
    @aeky168 2 ปีที่แล้ว +1

    What is advantage of 3+3 design?

    • @thepartnership800
      @thepartnership800  2 ปีที่แล้ว

      Response from Dr. London: "easy to understand and conduct;
      well known in the oncology scientific community;
      requires very little time from a statistician, and therefore could be a lower cost"